Is Boston Scientific Corporation overvalued?

Boston Scientific Corporation (BSX) looks undervalued — trading about 70% below its fair value.

Undervalued

Price

$44.34

Fair value

$75.51

Current P/E

22.9

Normal P/E

38.9

Market cap

$64.27B

Dividend yield

0.0%

Return on equity

13.9%

Sector

Healthcare

Fair value compares BSX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks